Trial Profile
A randomised, double-blind, placebo-controlled trial of Lactobacillus reuteri DSM 17938 in patients with severe infantile colic
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Colic
- Focus Therapeutic Use
- 30 Nov 2015 New trial record